Big pharma, Medical device, Partnering, Pharma

Sanofi and Medtronic form a pharma partnership

Posted on 16 June 2014

Tags: , , , ,

Sanofi was teaming up with U.S. medical device maker Medtronic in a pharma partnership for diabetes.

The announcement comes as Sanofi seeks to defend its No.2 spot in a global diabetes market worth over $40 billion, at a time when top-selling drug Lantus, the world's most prescribed insulin, is set to lose patent protection early next year.

Sanofi and Medtronic will initially cooperate on developing drug-device combinations and offering care management services for diabetes patients.

Depending on the results, they will consider other areas for collaboration, the companies said in a statement.

For further deal information visit Current Agreements (subscription required)

 

Related

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply